Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills

Tianwang Buxin pill (TWBXP) is an ancient Chinese classic prescription. Liquiritin, deoxyschizandrin, and tanshinone II A are three bioactive components in TWBXP, which have been proven to be closely related to the therapy effect of neurodegenerative disease. Their contents are very low in TWBXP. In...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Xu, Sicen Wang, Xiaofang Hou, Changshan Sun
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Analytical Methods in Chemistry
Online Access:http://dx.doi.org/10.1155/2019/3150942
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564714753753088
author Dan Xu
Sicen Wang
Xiaofang Hou
Changshan Sun
author_facet Dan Xu
Sicen Wang
Xiaofang Hou
Changshan Sun
author_sort Dan Xu
collection DOAJ
description Tianwang Buxin pill (TWBXP) is an ancient Chinese classic prescription. Liquiritin, deoxyschizandrin, and tanshinone II A are three bioactive components in TWBXP, which have been proven to be closely related to the therapy effect of neurodegenerative disease. Their contents are very low in TWBXP. In this study, we used a diode array detector (DAD) to perform a full wavelength scanning in order to choose a most suitable detection wavelength to establish an HPLC method for the simultaneous determination of these three components in TWBXP. Various chromatographic conditions were investigated to verify its applicability. Finally, a Kromasil C18 column (250 × 4.6 mm, 5 μm) thermostated at 30°C, mobile phase as 0.2% phosphoric acid solution (eluent A), and 0.1% phosphoric acid-acetonitrile solution (eluent B) were used. Both external standard method and internal standard method were used for quantification. The results showed that both methods were simple and convenient in operation without special pretreatment and exhibits excellent precision, repeatability (RSD < 3.0%), good linearity (R2 > 0.9990), and good recoveries (recovery value between 95% and 105%). Because of the low contents in samples, the internal standard method provided a better accurate result than the external standard method. The stability results showed the sample became stable within 24 hours at room temperature. The method provides a convenient and effective way for the quality control of TWBXP, and it can help the research about AD in the future.
format Article
id doaj-art-dc008b81006a432384a2d11a40a7838e
institution Kabale University
issn 2090-8865
2090-8873
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Analytical Methods in Chemistry
spelling doaj-art-dc008b81006a432384a2d11a40a7838e2025-02-03T01:10:27ZengWileyJournal of Analytical Methods in Chemistry2090-88652090-88732019-01-01201910.1155/2019/31509423150942Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin PillsDan Xu0Sicen Wang1Xiaofang Hou2Changshan Sun3School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, ChinaSchool of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, ChinaSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, ChinaTianwang Buxin pill (TWBXP) is an ancient Chinese classic prescription. Liquiritin, deoxyschizandrin, and tanshinone II A are three bioactive components in TWBXP, which have been proven to be closely related to the therapy effect of neurodegenerative disease. Their contents are very low in TWBXP. In this study, we used a diode array detector (DAD) to perform a full wavelength scanning in order to choose a most suitable detection wavelength to establish an HPLC method for the simultaneous determination of these three components in TWBXP. Various chromatographic conditions were investigated to verify its applicability. Finally, a Kromasil C18 column (250 × 4.6 mm, 5 μm) thermostated at 30°C, mobile phase as 0.2% phosphoric acid solution (eluent A), and 0.1% phosphoric acid-acetonitrile solution (eluent B) were used. Both external standard method and internal standard method were used for quantification. The results showed that both methods were simple and convenient in operation without special pretreatment and exhibits excellent precision, repeatability (RSD < 3.0%), good linearity (R2 > 0.9990), and good recoveries (recovery value between 95% and 105%). Because of the low contents in samples, the internal standard method provided a better accurate result than the external standard method. The stability results showed the sample became stable within 24 hours at room temperature. The method provides a convenient and effective way for the quality control of TWBXP, and it can help the research about AD in the future.http://dx.doi.org/10.1155/2019/3150942
spellingShingle Dan Xu
Sicen Wang
Xiaofang Hou
Changshan Sun
Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
Journal of Analytical Methods in Chemistry
title Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
title_full Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
title_fullStr Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
title_full_unstemmed Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
title_short Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
title_sort preliminary studies on liquiritin deoxyschizandrin and tanshinone ii a as potential anti neurodegenerative disease agent determination by reverse phase liquid chromatography in tianwang buxin pills
url http://dx.doi.org/10.1155/2019/3150942
work_keys_str_mv AT danxu preliminarystudiesonliquiritindeoxyschizandrinandtanshinoneiiaaspotentialantineurodegenerativediseaseagentdeterminationbyreversephaseliquidchromatographyintianwangbuxinpills
AT sicenwang preliminarystudiesonliquiritindeoxyschizandrinandtanshinoneiiaaspotentialantineurodegenerativediseaseagentdeterminationbyreversephaseliquidchromatographyintianwangbuxinpills
AT xiaofanghou preliminarystudiesonliquiritindeoxyschizandrinandtanshinoneiiaaspotentialantineurodegenerativediseaseagentdeterminationbyreversephaseliquidchromatographyintianwangbuxinpills
AT changshansun preliminarystudiesonliquiritindeoxyschizandrinandtanshinoneiiaaspotentialantineurodegenerativediseaseagentdeterminationbyreversephaseliquidchromatographyintianwangbuxinpills